Immune Therapeutics, Inc. announced the appointment of Kelly O'Brien Wilson, age 51, as Chief Operating Officer filling the previously vacant position. In that role, Ms. Wilson will be responsible for overseeing the company's core business units and subsidiaries and for working directly with the Company's international leadership, assisting with country management organization and functions. She will work to maximize the potential of the Company's growing portfolio of products, many of which are in a combination of approved and growth phases.

Ms. Wilson brings over 25 years of leadership, technology, and operational experience to Immune. She has held senior management and development roles with both startups and large corporations in the private, public, and government sectors across multiple industries including biotechnology, manufacturing, and computer software. She was the Chief Technology Officer and Director of Human Resources at Immune from 2015-2020 and has experience managing many different business departments including information technology, human resources, and corporate operations.

Ms. Wilson graduated with honors from the University of Central Florida with a master's degree in systems design and a bachelor's degree in English.